Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 5/3/2014 |
| Start Date: | March 2007 |
| End Date: | December 2008 |
| Contact: | Kenneth A Ellenbogen, MD |
| Email: | kellenbogen@mcvh-vcu.edu |
| Phone: | 804-828-7576 |
Prospective Analysis of the Wolf Minimaze Procedure for Treatment of Atrial Fibrillation
The purpose of this study is to assess the efficacy of minimally invasive surgery for
atrial fibrillation.
atrial fibrillation.
Patients who are undergoing or who have undergone minimally invasive surgery for atrial
fibrillation will be followed prospectively. At 6 to 9 months, 1 and two years post surgery
follow-up subjects will receive a trans-telephonic monitor to wear for approximately 1
month, and will submit transmissions on a daily basis. Episodes of atrial fibrillation will
be documented during this time. The overall efficacy of the procedure will be assessed based
on the freedom from atrial fibrillation at the time of transtelephonic monitoring.
fibrillation will be followed prospectively. At 6 to 9 months, 1 and two years post surgery
follow-up subjects will receive a trans-telephonic monitor to wear for approximately 1
month, and will submit transmissions on a daily basis. Episodes of atrial fibrillation will
be documented during this time. The overall efficacy of the procedure will be assessed based
on the freedom from atrial fibrillation at the time of transtelephonic monitoring.
Inclusion Criteria:
- 18 or older
- paroxysmal, persistent, or permanent atrial fibrillation
Exclusion Criteria:
- concomitant heart surgery requiring open thoracotomy
We found this trial at
1
site
Click here to add this to my saved trials
